Consistently, analysis of public ChIP-Seq data curated in the ReMap 2022 database (15) supported binding of p53 to the FOXQ1 promoter across multiple cell types, including SW480 CRC cells (Fig. S2A). This evidence concerns the gene FOXQ1 and colorectal carcinoma.